About Journal of Cancer Research and Immuno-Oncology
Journal of Cancer Research and Immuno-Oncology is a fast-developing open access journal in the field of cancer research. It focuses on becoming one of the best peer reviewed journal in the field of cancer research. Journal of Cancer Research and Immuno-Oncology covers a broad scope for the authors to make their valuable contributions in cancer biology, tumor, radiology, metastatis, cancer immunotherapy, oncology, radiation therapy etc
This Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on any array of latest cancer research and Immuno-Oncology. The Journal of Cancer Research and Immuno-Oncology is a Peer Reviewed Open Access Journal supported by universally prominent Editorial Board members. Abstracts and full texts of all articles published by Journal of Cancer Research and Immuno-Oncology are freely accessible to everyone.
The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Journal of Cancer Research and Immuno-Oncology or outside experts; approval of at least two independent reviewers followed by the editor is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
Journal of Cancer Research and Immuno-Oncology is a broad-based journal founded on two key tenets: To publish the most exciting researches related to Cancer and Immuno-Oncology. Secondly, to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes. It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals and researchers and professional bodies and institutions.
Journal of Cancer Research and Immuno-Oncology strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. Journal of Cancer Research and Immuno-Oncology will keep up-to- date with latest advances in the field of Cancer Research and Immuno-Oncology. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Cancer Research and Immuno-Oncology are freely accessible to everyone immediately after publication. Journal of Cancer Research and Immuno-Oncology supports the Bethesda Statement on Open Access Publishing.
Longdom Publishing SL is using Online Review and Editorial Manager Systems for quality review process. Editorial Manager System is an online submission and review system, where authors can submit manuscripts and track their progress. Reviewers can download manuscripts and submit their opinions. Editors can manage the whole submission/review/revise/publish process. Publishers can see what manuscripts are in the pipeline awaiting publication. E-mail is sent automatically to concerned persons when significant events occur.
bmit manuscript https://www.longdom.org/submissions/cancer-research-immuno-oncology.htmlor mail us the manuscript to firstname.lastname@example.org
Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.
Journal of Cancer Research and Immuno-Oncology
Whatsapp No: +1-504-608-2390
Mail ID: email@example.com